Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it “taxol”.Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.
The global Paclitaxel market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage Market Size & Forecast, Major Company of Product Type etc. :
Demand Coverage Market Size & Forecast, Consumer Distribution :
Get More Information about this Report and TOC @ https://www.planetmarketreports.com/reports/global-paclitaxel-market-4361
Company Coverage Sales data, Main Products & Services etc. :
Hainan Yew Pharm
Major Region Market
Middle East & Africa